Skip to main content

Migrant status is not a disadvantage following heart surgery

Advertisement

Certain groups are generally under-represented in clinical trials. This applies in particular to people with a migrant background, women and older people. As a result, treatment outcomes in these groups may, in some circumstances, be less favourable than in the general population. A study has now investigated whether there is a statistical link between these under-represented groups and mortality rates in the treatment and rehabilitation of coronary artery disease. Data from more than 15,000 patients who had undergone coronary intervention between 2009 and 2018 were analysed. Contrary to the initial assumption that these groups would have poorer outcomes, age was the only factor that made a statistically significant difference in mortality following serious cardiovascular events. However, lead author Nathalia Gonzalez-Jaramillo, from the University of Bern, emphasises that these findings, which were obtained in Switzerland – a country with a high standard of healthcare – cannot necessarily be generalised to other countries. Whilst migrants were not at a disadvantage with regard to any of the parameters examined, other surprising results emerged. For instance, the researchers were able to demonstrate that women and older people are less likely to participate in rehabilitation programmes. The researchers state that raising awareness is needed in this area, particularly as the positive effect of participating in these programmes on overall and cardiovascular mortality was evident across all groups. The study showed that, overall, only around a third of all eligible patients take part in the outpatient programmes on offer. In future, greater use is to be made of telemedicine and mobile health. Reference: University of Bern. Clinical outcomes and cardiac rehabilitation in underrepresented groups after percutaneous coronary intervention: an observational study, Europ J of Prev Card 2021;https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwab204/6459592

#migrantstatus #studydesign #cardiovasculardisease #heart #cardiology #internalmedicine #cardiovascularsystem #medicine #medimpressions

  • Author

    Gernot Hofer

More on this topic
Hormones

Low testosterone in men: symptoms, causes and treatment

Fatigue, a reduced sex drive, and a lack of energy: these symptoms can have many causes. One possible explanation is a testosterone deficiency. However, it is not possible to determine whether testosterone levels are actually too low based solely on the symptoms or on a single blood test result.

Men's health
Men's health

PSA level: What does it mean, and when is it too high?




The PSA level is one of the best-known laboratory test results relating to the prostate. Many men come across it for the first time during a screening examination or when having symptoms investigated. An abnormal result often raises questions: Is this already a sign of prostate cancer? What levels are considered normal?

Prostate
Pollen allergy

The right diet for hay fever

Anyone suffering from hay fever should pay particular attention to their diet so as not to make the symptoms any worse.

Nutrition
Urology

Prostate health: What men need to know

The prostate is a gland in a man’s body that is only the size of a chestnut, but it plays a crucial role in well-being, urinary function and male sexuality. Benign enlargement and prostate cancer become more common in older age.

Prostate